Docosahexaenoic acid-dependent iron accumulation in oligodendroglia cells protects from hydrogen peroxide-induced damage

Journal of Neurochemistry

Volumn 105, Issue 4, 2008, Pages 1325-1335

  Brand, Annette ^a   Schonfeld, Eldi ^a   Isharel, Ilanit ^a   Yavin, Ephraim ^a,b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Apoptosis; Docosahexaenoic acid; Iron; Lipid asymmetry; Oligodendroglial cells; Oxidative stress

Indexed keywords

DOCOSAHEXAENOIC ACID; HYDROGEN PEROXIDE; IRON; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; DOCOSAHEXAENOIC ACIDS; HYDROGEN PEROXIDE; IRON; LIPID PEROXIDATION; OLIGODENDROGLIA; OXIDATIVE STRESS; RATS;

EID: 42549119439     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05234.x     Document Type: Article

References (54)

1. Aebi H. E. (1984) Catalase, in Methods of Enzymatic Analysis (Bergmeyer H. U., Bergmeyer J. Grassl M., eds Vol. 3, pp. 273 286. Verlag Chemie, Weinheim, Germany.
2. Barcelo-Coblijn G., Hogyes E., Kitajka K., Puskas L. G., Zvara A., Hackler Jr. L., Nyakas C., Penke Z. Farkas T. (2003) Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc. Natl Acad. Sci. USA 100, 11321 11326.
3. Bartzokis G. (2004) Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol. Aging 25, 5 18.
4. Bartzokis G., Tishler T. A., Lu P. H., Villablanca P., Altshuler L. L., Carter M., Huang D., Edwards N. Mintz J. (2007) Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol. Aging 28, 414 423.
5. Beard J. (2007) Recent evidence from human and animal studies regarding iron status and infant development. J. Nutr. 137, 524S 530S.
6. Blomgren K. Hagberg H. (2006) Free radicals, mitochondria, and hypoxia-ischemia in the developing brain. Free Radic. Biol. Med. 40, 388 397.
7. Bradford M. M. (1986) A rapid sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 238 259.
8. Brand A. Yavin E. (2001) Early ethanolamine phospholipid translocation marks stress-induced apoptotic cell death in oligodendroglial cells. J. Neurochem. 78, 1208 1218.
9. Brand A. Yavin E. (2005) Translocation of ethanolamine phosphoglyceride is required for initiation of apoptotic death in OLN-93 oligodendroglial cells. Neurochem. Res. 30, 1257 1267.
10. Brand A., Gil S. Yavin E. (2000) N-methyl bases of ethanolamine prevent apoptotic cell death induced by oxidative stress in cells of oligodendroglia origin. J. Neurochem. 74, 1596 1604.
11. 2-induced apoptotic cell death via ERK activation. J. Neurochem. 76, 910 918.
12. Burdo J. R. Connor J. R. (2003) Brain iron uptake and homeostatic mechanisms: an overview. BioMetals 16, 63 75.
13. Burton K. (1968) Determination of DNA concentration with diphenylamine. Methods Enzymol. 12B, 163 166.
14. Butterfield D. A., Perluigi M. Sultana R. (2006) Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur. J. Pharmacol. 545, 39 50.
15. Cammer W. (1984) Oligodendrocyte associated enzymes, in Oligodendroglia (Norton W. T., ed pp. 199 232. Plenum Press, New York.
16. Carlson E. S., Stead J. D., Neal C. R., Petryk A. Georgieff M. K. (2007) Perinatal iron deficiency results in altered developmental expression of genes mediating energy metabolism and neuronal morphogenesis in hippocampus. Hippocampus, 17, 679 691.
17. Das D. K. Maulik N. (2006) Cardiac genomic response following preconditioning stimulus. Cardiovasc. Res. 70, 254 263.
18. Dringen R. Hamprecht B. (1997) Involvement of glutathione peroxidase and catalase in the disposal of exogenous hydrogen peroxide by cultured astroglial cells. Brain Res. 759, 67 75.
19. Eisenstein R. S. (2000) Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu. Rev. Nutr. 20, 627 662.
20. Esterbauer H. Cheeseman K. H. (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186, 407 421.
21. Fenton H. J. H. (1894) Oxidation of tartaric acid in presence of iron. J. Chem. Soc. 65, 899 903.
22. Fernandes G., Troyer D. A. Jolly C. A. (1998) The effects of dietary lipids on gene expression and apoptosis. Proc. Nutr. Soc. 57, 543 550.
23. Ferriero D. M. (2001) Oxidant mechanisms in neonatal hypoxia-ischemia. Dev. Neurosci. 23, 198 202.
24. Floyd R. A. (1999) Antioxidants, oxidative stress, and degenerative neurological disorders. Proc. Soc. Exp. Biol. Med. 3, 236 245.
25. Gidday J. M. (2006) Cerebral preconditioning and ischaemic tolerance. Nat. Rev. Neurosci. 7, 437 448.
26. Gutterer J. M., Dringen R., Hirrlinger J. Hamprecht B. (1999) Purification of glutathione reductase from bovine brain, generation of an antiserum, and immunocytochemical localization of the enzyme in neural cells. J. Neurochem. 73, 1422 1430.
27. Hengst U., Albrecht H., Hess D. Monard D. (2001) The phosphatidylethanolamine-binding protein is the prototype of a new family of serine protease inhibitors. J. Biol. Chem. 276, 535 540.
28. Katsuki H. Okuda S. (1995) Arachidonic acid as a neurotoxic and neurotrophic substance. Prog. Neurobiol. 46, 607 636.
29. Keller E. T., Fu Z. Brennan M. (2004) The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem. Pharmacol. 68, 1049 1053.
30. Lee D. W. Andersen J. K. (2006) Role of HIF-1 in iron regulation: potential therapeutic strategy for neurodegenerative disorders. Curr. Mol. Med. 6, 883 893.
31. Liu M., Xiao D. S. Qian Z. M. (2007) Identification of transcriptionally regulated genes in response to cellular iron availability in rat hippocampus. Mol. Cell. Biochem. 300, 139 147.
32. Maher P. (2005) The effects of stress and aging on glutathione metabolism. Ageing Res. Rev. 4, 288 314.
33. Mandel S., Amit T., Reznichenko L., Weinreb O. Youdim M. B. (2006) Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. Mol. Nutr. Food Res. 50, 229 234.
34. Maynard C. J., Cappai R., Volitakis I., Cherny R. A., White A. R., Beyreuther K., Masters C. L., Bush A. I. Li Q. X. (2002) Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J. Biol. Chem. 277, 44670 44676.
35. Mazza M., Pomponi M., Janiri L., Bria P. Mazza S. (2007) Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 12 26.
36. Ober M. D. Hart C. M. (1998) Attenuation of oxidant-mediated endothelial cell injury with docosahexaenoic acid: the role of intracellular iron. Prostaglandins Leukot. Essent. Fatty Acids 59, 127 135.
37. Ong W. Y. Halliwell B. (2004) Iron, atherosclerosis, and neurodegeneration: a key role for cholesterol in promoting iron-dependent oxidative damage? Ann. N Y Acad. Sci. 1012, 51 64.
38. Richter-Landsberg C. Besser A. (1994) Effects of organotins on rat brain astrocytes in culture. J. Neurochem. 63, 2202 2209.
39. Richter-Landsberg C. Heinrich M. (1996) OLN-93: a new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J. Neurosci. Res. 45, 161 171.
40. Riemer J., Hoepken H. H., Czerwinska H., Robinson S. R. Dringen R. (2004) Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells. Anal. Biochem. 331, 370 375.
41. Schonfeld E., Yasharel I., Yavin E. Brand A. (2007) Docosahexaenoic acid enhances iron uptake by modulating iron transporters and accelerates apoptotic death in PC12 cells. Neurochem. Res. 32, 1673 1684.
42. Serrano F. Klann E. (2004) Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res. Rev. 3, 431 443.
43. Sheu S. S., Nauduri D. Anders M. W. (2006) Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim. Biophys. Acta 1762, 256 265.
44. Sleight R. G. Pagano R. E. (1983) Rapid appearance of newly synthesized phosphatidylethanolamine at the plasma membrane. J. Biol. Chem. 258, 9050 9058.
45. Terman A. Brunk U. T. (2006) Oxidative stress, accumulation of biological 'garbage', and aging. Antioxid. Redox Signal. 8, 197 204.
46. Thomas M. Jankovic J. (2004) Neurodegenerative disease and iron storage in the brain. Curr. Opin. Neurol. 17, 437 442.
47. Ward K. L., Tkac I., Jing Y., Felt B., Beard J., Connor J., Schallert T., Georgieff M. K. Rao R. (2007) Gestational and lactational iron deficiency alters the developing striatal metabolome and associated behaviors in young rats. J. Nutr. 137, 1043 1049.
48. Yao D., Shi W., Gou Y., Zhou X., Yee Aw T., Zhou Y. Liu Z. (2005) Fatty acid-mediated intracellular iron translocation: a synergistic mechanism of oxidative injury. Free Radic. Biol. Med. 39, 1385 1398.
49. Yavin E. Brand A. (2005) From intramolecular asymmetries to raft assemblies: a short guide for the puzzled, in Lipidomics (Mattson M. P., ed Membrane microdomain signaling pp. 1 14. Humana Press, Totowa, NJ.
50. Yavin E., Brand A. Green P. (2002) Docosahexaenoic acid abundance in the brain: a biodevice to combat oxidative stress. Nutr. Neurosci. 5, 149 157.
51. Yehuda S., Rabinovitz S. Mostofsky D. I. (2005) Essential fatty acids and the brain: from infancy to aging. Neurobiol. Aging 26S, S98 S102.
52. Yeung K., Seitz T., Li S. et al. (1999) Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401, 173 177.
53. Youdim M. B., Fridkin M. Zheng H. (2005) Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. Mech. Ageing Dev. 126, 317 326.
54. Zecca L., Youdim M. B., Riederer P., Connor J. R. Crichton R. R. (2004) Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863 873.